Transcoronary gene delivery represents a desirable option to achieve global myocardial transgene expression but still requires aggressive surgical preparation in rodents. We therefore developed a catheter-based approach for cardiac gene transfer in the closed chest rat. A double-lumen balloon catheter was used to create aortic occlusion for specific infusion of adenoviral vectors carrying a b-galactosidase transgene (1 Â 10 11 PFU) into the coronaries. Simultaneously, venous return was obstructed by a second balloon catheter in the right atrium. To prolong viral incubation time, we induced a transient cardiac arrest (2 and 5 min) by a combination of acetylcholine and the b-receptor antagonist, esmolol. At 72 h after transfection, the hearts showed a homogeneous and widespread b-galactosidase expression, and the transduction efficiency increased and up to about 43% of cardiac myocytes (histochemistry) with a 400-fold increase of b-galactosidase activity (luminescence assay) compared to sham-operated hearts. Pharmacological treatment aimed at increasing vascular permeability (SNAP and histamine) did not bring about synergistic effects on transfection efficiency. In addition, the method using high intracoronary pressure delivery (4300 mmHg) in a singlepass manner resulted in rather sparse b-galactosidase expression in the myocardium (3-5% of cardiac myocytes). Therefore, the percutaneous gene delivery system described here provides a simple and minimally invasive procedure that represents a novel strategy for a homogeneous and highly efficient in vivo gene transfer to rodent hearts. Our results also suggest that prolongation of viral incubation time is an effective means for achieving highly efficient myocardial gene transduction.
Introduction
Cardiac gene therapy offers a genuine therapeutic potential for a number of inherited and acquired cardiac disorders such as congestive heart failure. 1, 2 Recent studies have demonstrated that adenovirus-mediated gene transfer can improve cardiac performance in failing hearts. [3] [4] [5] [6] [7] [8] To achieve this therapeutic goal, it is obvious that myocardial gene transfer needs to be coupled to a global and highly efficient gene transduction to its cellular target. 1, 2 The transcoronary route for gene delivery represents a conceptually elegant option to achieve a widespread transfection of the entire myocardium. 9 However, protocols developed in rodents so far require a relatively aggressive surgical preparation. 4, 7, 10 In the open-chest rat, Hajjar et al 7 injected adenoviral vectors into the aortic root with concomitant cross-clamping of the aorta and the pulmonary artery, leading to the development of high coronary pressure above 300 mmHg. More recently, a new catheter-based approach was introduced by Beeri et al, 11 who used an arterial balloon catheter to create an aortic occlusion in order to direct the viral suspension into the coronaries within 10 s. While this delivery system is rather inefficient, it can be substantially improved by use of echo contrast microbubbles and concomitant sonication. Therefore, it appears necessary to optimize multiple factors that have been previously identified by Donahue et al 12 in an isolated heart model also under in vivo conditions. 13, 14 These authors have demonstrated that coronary flow, virus titer, viral exposure time and endothelial permeabilization are key factors affecting the efficiency of intracoronary gene delivery. In addition, transcoronary gene transfer is favored by high intravascular pressure as a major driving force to enhance the viral extravasation as shown in rats, 7 rabbits 13, 14 and swine. 15 In view of these findings, the aim of the present study was to develop a catheter-based delivery system that permits a homogenous and efficient gene transfer in the close-chest rodent heart.
Results
In the present study, we assumed that a prolonged viral exposure time might be crucial in optimizing myocardial gene delivery in vivo. To this end, we have chosen a combination of acetylcholine (ACh) and esmolol to arrest the heart. After the onset of cardiac arrest, the viral suspension was gently instilled into the coronaries with a mean infusion pressure of 45.4715 mmHg. During the asystolic period, aortic pressure (AP) was maintained at 19.273.2 mmHg because the mechanical action was fully suspended. This no-flow condition permitted the viral suspension to remain within the coronary vessels for extended periods of time. At the end of cardiac arrest, the spontaneous heart beat could be entirely resumed by bolus injection of the b-receptor agonist epinephrine suprarenin, (0.02 mg/kg) together with cardiopulmonary resuscitation. In this way, the systemic circulation could be successfully re-established, as indicated by the gradual recovery of the AP close to the control level ( Figure 1 and Table 1 ). Cardiac function was little affected by the transient no-flow ischemia, as indicated by the recovery of the heart rate and contractile parameters such as left ventricular developing pressure Figure 1 (a) Functional isolation of coronary circulation by simultaneous aortic occlusion created by the arterial balloon (AB) and right atrial occlusion by the venous balloon catheter (VB). (b) Cardiac-specific delivery is illustrated by injection of methylene blue via the arterial balloon catheter with simultaneous inflation of AB and VB. Note that there is no staining of extarcardiac tissues. (c) Representative registrations of the AP (upper panel) and ECG (lower panel) during cardiac transfection. 1, inflation of VB; 2, inflation of AB; 3, cardiac arrest by esmolol þ ACh; 4, injection of adenoviral suspension; 5, deflation of AB and VB/injection of suprarenin; 6, cardiopulmonary resuscitation; 7, infusion of suprarenin and NaHCO 3 . LCA, left coronary artery. Figure 2 ). Mechanical ventilation with pure oxygen in the anesthetized rats rendered the PaO 2 values around 300 mmHg, and reverted to the control value after transitory drop due to cardioplegia, suggesting that pulmonary function was not affected by 5 min ischemia. The serum creatinine levels were not altered after 60 min and 24 h of reperfusion, suggesting that the renal ischemia/reperfusion injury was functionally negligible in the cardiac arrest model of the rats. Of the 32 rats undergoing the protocol of cardiac arrest, all animals recovered and woke up after being weaned from ventilation. Only two rats died due to postoperative blood loss, which resulted in total mortality less than 10% during follow-up. For adenoviral transfection to the hearts, 500 ml of Ad.LacZ virus (1 Â 10 11 PFU) was instilled gently into the coronary vasculature of the asystolic heart. The extent of transgene expression was evaluated 3 days after transfection by histochemistry (X-gal staining) as well as by measurement of enzymatic activity. As shown in Figure  3a , X-gal staining of cross-sectioned hearts was homogeneously distributed in left and right ventricles of Ad.LacZ-transfected hearts, which was in direct contrast to the sham-operated hearts which showed absolutely no positive X-gal staining in the heart section. On the cellular level, intense X-gal staining was found predominantly within cardiomyocytes (CMs) (right panel). The average transfection efficiency, estimated by measuring the area of b-gal-positive CMs in the heart sections, was 4375.2% (range 23-76%, n¼5; Figure 3b ). In line with the histological analysis, the b-galactosidase enzymatic activity increased to 739 6447497 436 counts/mg protein/10 s, that is, about 400-fold the background in the sham-operated rats (16507642 counts/mg protein/10 s; Figure 3c ). In a later series of experiments, when the incubation time was shortened to 1.5 min, the transfection efficiency declined to 18.2712.0% (n¼4; Figure 3b ) and the enzymatic activity in those heart reached 334 3557226 512 counts/mg protein/10 s (Figure 3c ).
The LacZ transgene expression was also verified by Western analysis using monoclonal antibodies against Escherichia coli b-galactosidase. Positive immunoblots were observed exclusively in those hearts transfected with Ad.LacZ, but not in the sham-operated hearts, indicating the specificity of cardiac transgene expression (data not shown).
To analyze the homogeneity of myocardial transfection, entire hearts were cut into serial sections from the apex to the base. Histochemical staining of these slices revealed that the distribution of b-gal-positive CMs was uniform throughout the regions of the heart. Consistently, the specific b-galactosidase activity was found to reach similar levels throughout the regions of the heart (Figure 4) .
To test the effects of endothelial permeabilization on the efficiency of myocardial gene transfer, we used two pharmacological agents known to increase the permeability of the endothelial barrier. SNAP (100 mmol/l) or histamine (1 mmol/l) was added to the initial washing solution as well as the viral suspension. Surprisingly, none of these agonists improved myocardial transfection efficiency (3477.8 and 4279.0% respectively, n¼4 in each group; Figure 3b ) compared to the standard 5-min Figure 2 The 5 min cardiac arrest did not affect the serum concentration of lactate and creatinine (Scr). Blood samples were collected before cardiac arrest (Con), and 60 min (60 min) and 24 hours (24 Hr) after cardiac arrest (n¼4). protocol. Likewise, the b-galactosidase activity ( Figure  3c ) and protein expression (data not shown) reached the same levels as those without additional pharmacological intervention. We finally also tested whether an adaptation of the transfection method developed by Hajjar et al 7 using high intracoronary pressure (HIP) as the major driving force for adenoviral vector delivery could be established using the aortic and right atrial balloons to mimic crossclamping the aorta and pulmonary artery. In these experiments, the heart beat was not stopped during aortic occlusion resulting in aortic root pressure peaking over 300 mmHg during the injection of virus solution (20 s). The HIP protocol, however, yielded rather sparse LacZ expression in the myocardium, occurring in only about 3% of CMs (n¼4; Figure 3b) . Likewise, the b-galactosidase activity was 30-fold less than that using the 5-min cardiac arrest protocol (20 840716 149 counts/ mg protein/10 s, Po0.001; Figure 3c ).
Discussion
In this study, we report a novel, catheter-based transfection protocol that yields a highly efficient adenoviral gene transfer into the rat heart in vivo. This transfection approach is characterized by the following features. (i) A through-lumen balloon catheter was designed to allow aortic occlusion and vector application to the coronaries via two separate lumens. (ii) Together with a second balloon inflated in the right atrium a closed compartment is generated that (iii) allows under conditions of pharmacologically induced cardiac arrest a prolonged transfection time up to 4.5 min. Consequently, this approach resulted in a homogeneous cardiac transfection targeting at least 40-45% of all cardiac myocytes.
Protocol for cardiac arrest
In the present study, we assumed that viral incubation time might be crucial in optimizing myocardial gene delivery in vivo. Therefore, a cardiac arrest without pressure development was a prerequisite to ensure optimal transition of viral vectors from the coronary lumen into the interstitial space. We found that the combination of ACh and esmolol induced a reversible and normothermic cardiac arrest with only transitory alteration of systemic blood parameters (Table 1) . This protocol for electromechanical cardiac arrest has been applied to more than 30 rats and all of them could be successfully resuscitated.
During the development of an optimal cardiac arrest protocol, we have also tested alternative methods, including electric fibrillation (30 V, 50 Hz) and vagal stimulation (12 V, 50 Hz), as well as intracoronary application of ACh, hyperkalemia (20 mmol/l) and adenosine (10-33 mmol/l). None of these interventions was suitable for our purpose of creating reversible cardiac arrest with minimal tissue damage. Agonists like ACh and adenosine alone as well as vagal stimulation and cardioplegic solution (hyperkalemia) led to only transitory bradycardia instead of desirable complete asystole.
Although a cardiac arrest of 5 min appears to be rather long, no signs of long-lasting organ injury were observed. Important functional parameters for heart, lung and kidney were only disturbed transiently and rapidly approached baseline values in about 10 min. In addition, no obvious behavioral abnormalities were observed, suggesting that a possible neuronal injury was rather minimal. The view is supported by a functional MRI study that shows that the energy metabolism and ion homeostasis of the brain recovered rapidly even after 10 min of cardiac arrest in rats. 16 Although rats could tolerate a relatively long period of no-flow ischemia, the transferability of the 5 min arrest protocol to large animals or humans must be seen with caution. The efficacy of the 2 min arrest protocol, however, may be sufficient for myocardial gene transfer of genes encoding paracrine acting products such as VEGF for angiogenic gene therapy. 
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Optimization of gene delivery
Several in vivo and ex vivo studies have addressed the question as to which parameters might be critical for an efficient myocardial gene transduction by adenoviral vectors. [12] [13] [14] Among the parameters tested, it was not surprising that prolongation of viral transfection time within the heart is important to elevate the efficiency of myocardial transfection. Having solved this problem by our cardiac arrest protocol, we could optimize the transfection efficiency. A cardiac arrest of 2 min (1.5 min transfection time) allowed to transfect 18% of CMs in rats, whereas an extended viral incubation time up to 4.5 min extended the positive CMs to 43%, suggesting that transfection efficiency correlates directly with viral incubation time. Similar to our results, Logeart et al 13 showed that a brief interruption of coronary flow is required to obtain significant gene transduction in vivo and the efficiency tended to increase with the time period of coronary artery occlusion. In the hamster model, Ikeda et al 3 recently demonstrated that the short incubation time (10-20 s) in single-pass manner yielded only 4-5% of myocardial gene transduction compared to a much higher efficiency when the incubation time was extended to 5 min during hypothermia together with cross-clamping of the ascending aorta and main pulmonary artery.
Another factor considered to influence the transfection rate in vivo is the endothelial barrier. Given the size of adenoviral particles (73 nm), which is too large to pass the normal endothelial barrier, disruption of the endothelial tight junction seemed to be a prerequisite to ensure access of the virus to the interstitium. 12 Therefore, factors capable of increasing endothelial permeability such as histamine, 3, 13 bradykinin and serotonin 17 also improve gene transduction in the isolated hearts and in vivo. Surprisingly, pretreatment of coronary vessels with the nitric oxide (NO) donor SNAP or histamine, substances well known to elevate vascular permeability, did not increase the transfection rate in our study. The lack of synergistic effects in the present experiments remains unclear but most likely is due to cardiac ischemia, known to increase coronary microvascular permeability per se.
18 Also note that ACh -used to induce cardiac arrest in the present study -is known to be able to trigger the release of endogenous NO, leading to the increase of vascular permeability via the cGMP cascade. 19 Moreover, the replacement of the blood by a crystalloid solution may also have enhanced vascular permeability. 17 Using our protocol to block the aortic outflow and the right atrial inflow, we were able to mimic under closechest conditions the protocol previously developed by Hajjar et al. 7 These authors used cross-clamping of the aorta and the pulmonary artery to perform adenoviral transfection under HIP. 4, 7 We found that injection of adenoviral vectors within a short period (20 s) into the aortic root without cardiac arrest resulted in aortic root pressures above 300 mmHg but yielded only sparse and uneven gene transduction of the myocardium (3-5% of CMs). Recently Beeri et al 11 also reported that cardiac gene delivery to the unarrested heart with HIP strategy, which is highly efficient in the open-chest model, was inefficient for myocardial gene transduction in the closed-chest setup. Transfection efficiency, however, could be considerably improved when treating the animals by a combination of echo contrast microbubbles together with sonication.
In summery, the gene delivery system described here provides a simple and minimally invasive procedure that yields a highly efficient and homogeneous transgene expression in the global myocardium. This catheterbased approach therefore may open up new prospects to explore the functional effects of the expression of therapeutic genes in rodents.
Materials and methods
This study was approved by the local committee and conducted according to German animal care legislation. Wistar (280-320 g) rats were intubated and anesthetized by mechanical ventilation with isoflurane (1.5% v/v; Abbott, Germany) in 100% oxygen. An incision was made in the middle of the neck to expose the right carotid artery and the internal jugular vein. A homemade 3F balloon catheter was placed into the right atrium via the internal jugular vein to obstruct the venous return. A 2F through-lumen balloon catheter built according to our specifications (Edwards Life Science, USA) was placed into the aortic root via the right carotid artery (Figure 1a) . After being rinsed with 200 ml saline containing 100 IU of heparin, the arterial catheter was connected to a pressure transducer (Statham P23XL) to measure AP. To estimate the cardiac function, the arterial catheter was intermediately advanced into the left ventricular cavity to measure the LVDP, and the first-order differentiation (dP/dt max ) was derived from the LVDP signals. All the physiological parameters were simultaneously recorded by a four-channel PowerLab system (ADInstruments).
After baseline measurements of physiological variables, the venous and the arterial balloons were simultaneously inflated to create right atrial and aortic occlusions. In all, 1 ml of washing solution (PBS) containing a combination of the b-receptor antagonist esmolol (1 mmol/l; Brevibloc s , Gensia, UK) and ACh (1 mmol/l; Sigma) was then injected into the coronaries through the arterial catheter to induce a transient cardiac arrest. 20 Thereafter, the coronary vascular system was gently filled with 500 ml of viral suspension containing adenoviral vectors or PBS (sham operation) in about 20 s. The viral vectors that carry the E. coli b-galactosidase gene under the control of the CMV promoter (Ad.LacZ) were applied in the range of 1.0-1.2 Â 10 11 PFU per animal. After injection, the viral vectors were allowed to incubate within the coronary vessels during the period of cardiac arrest (for 5 min and shortened to 2 min in a later series of experiments). For restoration of spontaneous circulation, bolus injection of epinephrine (0.02 mg/kg; Hoechst, Germany) and sodium bicarbonate (0.5 mEq/ kg; Braun, Germany) was given intravenously, and cardiopulmonary resuscitation was performed at a compression rate of about 200 per minute to build the AP up to 50 mmHg. Successful return of spontaneous circulation was confirmed by the gradual recovery of the heart beat as well as the AP. For analysis of blood gas and hematocrit, arterial blood was sampled after 1, 10, 30 and 60 min of reperfusion. At 1 h after re-establishment Myocardial gene delivery Z Ding et al of stable arterial blood pressure, the wound was treated with lidocaine and sutured. The animals were weaned from the respirator, extubated and placed in an oxygenenriched environment for 1 h before being returned to their cages. In some experiments, blood samples were also collected 24 h after cardiac arrest, and the serum concentrations of lactate and creatinine were measured according to standard clinical methods.
To test the effect of vascular permeabilization on transfection efficiency, in some experiments, SNAP (100 mmol/l) or histamine (1 mmol/l) was added to the washing solution as well as to the virus suspension.
Additionally, we also tested the transfection efficiency of high intravascular pressure strategy (HIP) analogous to a previously described technique by Hajjar et al. 7 In these experiments, we used the venous and arterial balloon catheters to create aortic and right atrial occlusions instead of using cross-clamping of the aorta and the pulmonary artery under open-chest conditions. In all, 300 ml of viral vectors (1.0-1.2 Â 10 11 PFU) was injected via the arterial catheter into the coronaries within 20 s. After injection, the venous and arterial balloons were immediately deflated and animals were ventilated for at least half an hour before return to their cages.
At 3 days after transfection, rats were euthanized and hearts were rapidly excised and transferred to a fixation solution (formaldehyde 2%, glutaraldehyde 0.2%, MgCl 2 2 mmol/l, EGTA 5 mmol/l, Triton-X 0.02% in PBS). Cryosections of the heart (60 mm) were then made transversely every 1 mm from the apex to the base. To visualize the b-galactosidase (b-gal) expression, sections were immersed in X-gal staining solution for 2-3 h at 371C (MgCl 2 2 mmol/l, K 4 [Fe(CN) 6 ] 5 mmol/l, K 3 [Fe(CN) 6 ] 5 mmol/l, X-gal 1 mg/ml, sodium deoxycholate 0.01%, Triton-X 0.02% in PBS). The transfection efficiency was estimated by calculating the percent area of b-gal-positive CMs in at least 10 independent fields (analySIS s 3.0 software, Olympus). b-Galactosidase activity was measured using the bgalacto-Star s kit (Tropix Inc., USA). Briefly, a piece of tissue (B100 mg) was homogenized in lysis reagent and the cell lysates were centrifuged at 10 000 g for 2 min (41C). Thereafter, 5 ml of the supernatant was added to 300 ml of reaction buffer and incubated at room temperature for 60 min. The light emission was measured at 251C for 10 s using a luminometer (LB9500 T, Wildbad, Germany). Protein content in cell lysate was determined from aliquots of each sample by Lowry assay. For detection of b-galactosidase on Western blot, cardiac proteins were separated by SDS-PAGE (7.5% separation gel) and transferred to nitrocellulose membranes. Blots were incubated using a murine antibody directed against E. coli b-galactosidase (1:1000; Sigma) followed by secondary rabbit anti-mouse antibodies coupled to horseradish peroxidase. Bound proteins were visualized using enhanced chemiluminescence (ECL) reagents (Amersham Pharmacia Inc.).
Data are presented as means7standard deviation (s.d.m.). b-Galactosidase activity was normalized to protein content. Statistical analysis was performed using one-and two-way analysis of variances (ANOVA) followed by Neumann-Keuls multiple comparison tests (Prism 3.00, GraphPad Software Inc.). A significant difference was assumed at Po0.05.
